Agomab raised $89M in a Series D financing round to support its broad fibrosis-focused pipeline.
Amount Raised
$89 Million
Round Type
Series D
AntwerpenBiotechnologyHealth CareScience And EngineeringInvestors
Description
Agomab has successfully raised $89 million in its Series D financing round. The funds will be utilized to advance its pipeline focused on fibrosis treatments.
Quick answer
Agomab raised $89 Million in a Series D round, dated October 25, 2024. Investors: Redmile Group. Agomab is based in Antwerpen, Antwerp, Belgium.
- How much did Agomab raise?
- Agomab raised $89 Million in a Series D round on October 25, 2024.
- Who invested in Agomab?
- Redmile Group is named as investors in this round.
- What does Agomab do?
- Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function.
- Where is Agomab based and how big is it?
- Agomab is based in Antwerpen, Antwerp, Belgium.
- Who are the decision-makers at Agomab?
- Fundz holds 1 contact at Agomab. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Agomab that raised within 45 days of this round, from Fundz verified event records.
- Mythic Therapeutics raised $30M on December 9, 2024.
- Maze Therapeutics raised $115M (Series D) on December 3, 2024.
- MAIA Biotechnology raised $2.4M (Seed) on October 28, 2024.
- MAIA Biotechnology raised $2.4M (Seed) on October 28, 2024.
- Garuda Therapeutics raised $48M on October 17, 2024.
- 22nd Century raised $1.2M (Seed) on September 27, 2024.
Who to call at Agomab, and when
A new round usually means Agomab is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Agomab raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Agomab, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Agomab. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Agomab raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Agomab raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.